Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+104.9%
Year-over-Year Change
Year-over-year net income growth rate
5Y CAGR
+104.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
36.1x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 1999.08% |
| 2024 | 169.69% |
| 2023 | 57.16% |
| 2022 | -226.97% |
| 2021 | 39.77% |
| 2020 | 55.30% |
| 2019 | 5.58% |
| 2018 | 9.63% |
| 2017 | -12.68% |
| 2016 | -34.49% |